Tag: physical sciences
-
Technique Devised for 3-D Alzheimer’s Brain Images
Researchers in New York applied an imaging technique that visualizes the build-up of amyloid-beta plaques in the brain associated with Alzheimer’s disease.
-
Refillable HIV Prevention Implant in Development
A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute.
-
American Heart Assn, Amazon Partner on Cloud Analytics
American Heart Association is offering grants for new computational tools against heart disease, with Amazon Web Services providing cloud computing resources.
-
Bacterial-Biopolymer Delivery System Designed for Vaccines
A biotechnology company and university lab developed a vaccine delivery technique that induces an immune response, combining bacteria and a polymer material.
-
Radiation Enhances Nanoparticle Cancer Treatments
Targeting tumors with chemotherapy delivered in nanoparticles, preceded with radiation, was shown in lab mice to boost treatments in a range of cancers.
-
Animal-Free Leather Company Gains $40M in Venture Funds
A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round.
-
3-D Printing Technique Devised for Replacement Cartilage
Biomedical engineers developed a process for directly printing replacement cartilage without the scaffolds needed in previous tissue engineering techniques.
-
Start-Up Developing Nanomedicines for Transplants
A spin-off enterprise from Medical University of South Carolina is creating drug delivery techniques that make it safer for patients needing organ transplants.
-
App Evaluates Chest Pain Patients for Discharge
A new iPhone app helps emergency physicians decide whether a patient with chest pain can be safely discharged from a hospital or needs further tests.
-
Immunotherapy Company Raises $70 Million in IPO
Selecta Biosciences, a biotechnology company developing treatments harnessing the immune system, is raising $70 million in its initial public offering.